Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation

Multiple myeloma (MM) is a clinically and genetically heterogeneous plasma cell (PC) malignancy. Whole-exome sequencing has identified therapeutically targetable mutations such as those in the mitogen-activated protein kinase (MAPK) pathway, which are the most prevalent MM mutations. We used deep se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lionetti, Marta, Barbieri, Marzia, Todoerti, Katia, Agnelli, Luca, Marzorati, Simona, Fabris, Sonia, Ciceri, Gabriella, Galletti, Serena, Milesi, Giulia, Manzoni, Martina, Mazzoni, Mara, Greco, Angela, Tonon, Giovanni, Musto, Pellegrino, Baldini, Luca, Neri, Antonino
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695180/
https://ncbi.nlm.nih.gov/pubmed/26090869
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados